What was recalled
This page synthesizes the molecular mechanism and clinical-context framework around rosemary extract as a natural antioxidant in commercial pet food. The framework focuses on what specific compounds drive the antioxidant activity (rather than treating rosemary extract as a generic natural preservative) and clarifies the species-specific seizure-threshold consideration that affects pet selection for dogs with documented epilepsy.
The active compound framework: rosemary extract antioxidant activity comes from approximately 100+ identified compounds in rosemary leaf, but two compounds dominate the functional activity. Carnosic acid is an abietane diterpene (C20 carbon skeleton with characteristic diterpene structure) with two ortho-positioned hydroxyl groups on the catechol ring; the catechol structure provides strong electron-donation capacity for free radical scavenging similar to other catechol antioxidants (caffeic acid, gallic acid). Carnosol is formed from carnosic acid through oxidative cyclization producing a lactone bridge; carnosol retains the catechol-like phenolic structure and antioxidant capacity but has different solubility and stability characteristics than carnosic acid. The two compounds typically occur together in rosemary leaf and extract preparations with carnosol forming progressively during processing and storage as carnosic acid undergoes oxidative conversion. The framework is well-characterized in phytochemistry literature and provides clear mechanistic basis for rosemary extract antioxidant function.
The commercial extract sourcing landscape includes: (i) dried rosemary leaf or leaf powder — minimum processing, ~0.2-1% active diterpene compounds, modest antioxidant capacity, often used in fresh or refrigerated pet food formulations rather than shelf-stable kibble; (ii) solvent extracts — produced using ethanol, hexane, or ethyl acetate solvent extraction of dried leaves; typical 5-10% active diterpene compounds with solvent-residue and color considerations affecting use; (iii) oleoresin extracts — produced through controlled solvent extraction with concentration of active compounds; 5-10% active diterpene compounds; the dominant commercial form for pet food preservation; (iv) supercritical CO2 extracts — produced through supercritical fluid extraction; 20-40% active diterpene compounds; cleaner solvent residue profile and reduced color contribution but higher production cost; (v) purified carnosic acid + carnosol concentrates — produced through column chromatography or other purification of supercritical extracts; 50-80%+ active diterpene compounds; specialty applications with highest concentration. Pet food inclusion typically uses oleoresin or supercritical extracts at 100-500 ppm of finished product to deliver 5-50 ppm active diterpene compounds.
Why it was recalled
The structural concerns have three layers. Layer one — "rosemary extract" on the ingredient panel does not specify standardization or active compound content: the ingredient name covers commercial products ranging from 0.2% to 80%+ active diterpene compounds with substantial variation in actual antioxidant capacity per unit ingredient. Pet food labels typically list "rosemary extract" without specifying concentration, leaving the framework variability invisible to consumer evaluation. The framework gap is similar to mixed tocopherol isomer composition disclosure.
Layer two — species-specific seizure threshold concern in dogs with epilepsy requires clinical context: rosemary leaf and rosemary extract have a documented seizure-threshold-lowering concern in dogs with diagnosed epilepsy. The concern is debated in veterinary literature with variable evidence: some veterinary epileptologists recommend strict avoidance based on case reports of seizure exacerbation with rosemary-containing food or supplement exposure; other practitioners consider the evidence inconclusive and do not recommend strict avoidance. The framework gap is that pet food labeling does not surface the species-specific consideration; pet owners with epileptic dogs may unknowingly select rosemary-extract-preserved pet food without recognizing the potential clinical relevance. Veterinary consensus is appropriately cautious for dogs with documented seizure disorders; most veterinary epileptologists recommend avoiding rosemary-containing foods as a precautionary measure even with debated evidence.
Layer three — processing stability and rosemary extract degradation during kibble manufacturing requires framework consideration: carnosic acid converts to carnosol progressively during processing and storage through oxidative cyclization. The conversion is gradual and produces compounds (carnosol) that retain antioxidant activity, so the framework is not necessarily a quality loss. However, very prolonged storage or high-temperature processing can degrade both carnosic acid and carnosol to compounds with reduced antioxidant capacity. The framework supports post-extrusion application of rosemary extract (similar to enzyme glaze application) for maximum activity preservation, though the framework is less critical for rosemary extract than for heat-sensitive enzymes since both carnosic acid and carnosol are relatively heat-stable at typical extrusion temperatures.
Health risks for your pet
Rosemary extract safety profile at typical pet food inclusion levels is generally favorable for the broad pet population. Carnosic acid, carnosol, and rosmarinic acid have extensive safety data and are on FDA GRAS lists. Theoretical safety considerations: (i) seizure threshold lowering in epileptic dogs — the documented framework concern requires clinical context; pet owners with epileptic dogs should discuss rosemary-containing pet food selection with veterinary epileptologists; (ii) uterine stimulant effects in pregnancy — rosemary has documented modest uterine stimulant activity at high doses; clinical relevance at typical pet food exposure levels is minimal but pregnant dogs and cats are typically managed on therapeutic gestation diets that may or may not contain rosemary extract; (iii) allergic sensitization — rare reports of dermatitis in pets with documented Lamiaceae family (rosemary, basil, oregano, sage, thyme) sensitivity; (iv) concurrent medication interactions — rosemary extract has modest hepatic cytochrome P450 inhibition activity at high doses; clinical relevance at typical pet food exposure is minimal but theoretical framework for pets on chronic P450-metabolized medications; (v) high-dose ingestion — gross overconsumption of pet food or supplements containing concentrated rosemary extract could theoretically produce GI upset, but typical inclusion levels are well below any documented adverse effect threshold.
The health-outcome framework for the general pet population at typical pet food rosemary extract inclusion (100-500 ppm finished product) is favorable. The framework concerns concentrate in specific clinical contexts (epilepsy, late pregnancy) rather than general use. Most pets consume rosemary-extract-preserved pet food without any documented adverse effects.
What to do if you bought affected product
Pet owners can navigate the rosemary extract framework meaningfully through several practical approaches: (1) recognize that "rosemary extract" on the panel does not specify standardization — commercial extracts range from 0.2% to 80%+ active diterpene compounds with substantial variation in actual antioxidant capacity; brands disclosing extract standardization or carnosic acid + carnosol content provide stronger transparency signal; (2) discuss with veterinarian before feeding rosemary-containing pet food to dogs with documented epilepsy — the seizure-threshold-lowering concern is debated in veterinary literature but most epileptologists recommend strict avoidance as a precautionary measure; many epileptic dogs are managed on prescription diets that may or may not contain rosemary; (3) look for combination natural preservative systems — rosemary extract + mixed tocopherols + citric acid combinations typically provide more complete coverage than any single ingredient alone; (4) store rosemary-extract-preserved pet food carefully — the general natural preservative storage framework applies (airtight container, cool dry location, attention to expiration date); (5) recognize that pets with Lamiaceae family allergies may react to rosemary — rare but possible; pets with documented basil, oregano, sage, thyme, or mint allergies may benefit from rosemary-extract-free pet food; (6) treat rosemary extract inclusion as evidence-supported natural preservation for the general pet population — outside the specific clinical context concerns (epilepsy, late pregnancy, Lamiaceae allergy), rosemary extract is a well-established and safe natural antioxidant for pet food preservation; (7) look for brands using oleoresin or supercritical CO2 extracts — these commercial forms provide higher concentration of active compounds with cleaner extract profiles than dried leaf or basic solvent extracts; (8) treat rosemary extract as one transparency signal among many — brand disclosure of extract standardization, processing approach, and combination preservative system is more meaningful than the presence of rosemary extract alone.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 treats rosemary extract inclusion as a positive natural-preservative signal per our published methodology, with no score deduction. The rubric does not currently differentiate rosemary extract standardization or active compound content. Future rubric extension under consideration: brands disclosing carnosic acid + carnosol content, extract standardization, and combination natural preservative systems would receive favorable scoring weight as transparency and formulation-quality signal. The species-specific epilepsy concern is not currently scored at the rubric tier but is documented in our condition-specific guides. Related framework coverage is across our rosemary extract controversy, rosemary extract explainer, mixed tocopherols explainer, citric and ascorbic acid antioxidants controversy, best dog food for epilepsy guide (which addresses dietary management considerations including rosemary avoidance), and other preservative controversy pages. For now, our recommendation: recognize rosemary extract as evidence-supported natural preservation for the general pet population, discuss with veterinarian before feeding to dogs with documented epilepsy, look for combination natural preservative systems, and treat extract standardization disclosure as a meaningful transparency signal.